138 related articles for article (PubMed ID: 28315254)
21. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening.
Krausz E; de Hoogt R; Gustin E; Cornelissen F; Grand-Perret T; Janssen L; Vloemans N; Wuyts D; Frans S; Axel A; Peeters PJ; Hall B; Cik M
J Biomol Screen; 2013 Jan; 18(1):54-66. PubMed ID: 22923784
[TBL] [Abstract][Full Text] [Related]
22. Proteomic techniques and activity-based probes for the system-wide study of proteolysis.
auf dem Keller U; Schilling O
Biochimie; 2010 Nov; 92(11):1705-14. PubMed ID: 20493233
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional Concentric FRET-Quantum Dot Probes for Tracking and Imaging of Proteolytic Activity.
Massey M; Li JJ; Algar WR
Methods Mol Biol; 2017; 1530():63-97. PubMed ID: 28150196
[TBL] [Abstract][Full Text] [Related]
24. Imaging Matrix Metalloproteinase Activity Implicated in Breast Cancer Progression.
Fields GB; Stawikowski MJ
Methods Mol Biol; 2016; 1406():303-29. PubMed ID: 26820965
[TBL] [Abstract][Full Text] [Related]
25. A fluorescence resonance energy transfer-based fluorometer assay for screening anti-coxsackievirus B3 compounds.
Cantera JL; Chen W; Yates MV
J Virol Methods; 2011 Jan; 171(1):176-82. PubMed ID: 21029747
[TBL] [Abstract][Full Text] [Related]
26. Fully Automated One-Step Production of Functional 3D Tumor Spheroids for High-Content Screening.
Monjaret F; Fernandes M; Duchemin-Pelletier E; Argento A; Degot S; Young J
J Lab Autom; 2016 Apr; 21(2):268-80. PubMed ID: 26385905
[TBL] [Abstract][Full Text] [Related]
27. Applications for a dual fluorescent human cytomegalovirus in the analysis of viral entry.
Sampaio KL; Jahn G; Sinzger C
Methods Mol Biol; 2013; 1064():201-9. PubMed ID: 23996259
[TBL] [Abstract][Full Text] [Related]
28. Photoconvertible fluorescent protein-based live imaging of mitochondrial fusion.
Owens GC; Edelman DB
Methods Mol Biol; 2015; 1313():237-46. PubMed ID: 25947670
[TBL] [Abstract][Full Text] [Related]
29. Functional measurement of local proteolytic activity in living cells of invasive and non-invasive tumors.
Ludwig T; Püttmann S; Bertram H; Tatenhorst L; Paulus W; Oberleithner H; Senner V
J Cell Physiol; 2005 Mar; 202(3):690-7. PubMed ID: 15389570
[TBL] [Abstract][Full Text] [Related]
30. Development and application of a GFP-FRET intracellular caspase assay for drug screening.
Jones J; Heim R; Hare E; Stack J; Pollok BA
J Biomol Screen; 2000 Oct; 5(5):307-18. PubMed ID: 11080689
[TBL] [Abstract][Full Text] [Related]
31. Development of a keratinocyte-based screening model for antipsoriatic drugs using green fluorescent protein under the control of an endogenous promoter.
Pol A; van Ruissen F; Schalkwijk J
J Biomol Screen; 2002 Aug; 7(4):325-32. PubMed ID: 12230886
[TBL] [Abstract][Full Text] [Related]
32. Whole-body subcellular multicolor imaging of tumor-host interaction and drug response in real time.
Yang M; Jiang P; Hoffman RM
Cancer Res; 2007 Jun; 67(11):5195-200. PubMed ID: 17545599
[TBL] [Abstract][Full Text] [Related]
33. Multiplexed assays by high-content imaging for assessment of GPCR activity.
Ross DA; Lee S; Reiser V; Xue J; Alves K; Vaidya S; Kreamer A; Mull R; Hudak E; Hare T; Detmers PA; Lingham R; Ferrer M; Strulovici B; Santini F
J Biomol Screen; 2008 Jul; 13(6):449-55. PubMed ID: 18519922
[TBL] [Abstract][Full Text] [Related]
34. Nanoscale imaging and quantification of local proteolytic activity.
Kusick S; Bertram H; Oberleithner H; Ludwig T
J Cell Physiol; 2005 Sep; 204(3):767-74. PubMed ID: 15744770
[TBL] [Abstract][Full Text] [Related]
35. Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironment.
Schwartz DR; Moin K; Yao B; Matrisian LM; Coussens LM; Bugge TH; Fingleton B; Acuff HB; Sinnamon M; Nassar H; Platts AE; Krawetz SA; Linebaugh BE; Sloane BF
Mol Cancer Res; 2007 May; 5(5):443-54. PubMed ID: 17510311
[TBL] [Abstract][Full Text] [Related]
36. Automated tracking of tumor-stroma morphology in microtissues identifies functional targets within the tumor microenvironment for therapeutic intervention.
Åkerfelt M; Bayramoglu N; Robinson S; Toriseva M; Schukov HP; Härmä V; Virtanen J; Sormunen R; Kaakinen M; Kannala J; Eklund L; Heikkilä J; Nees M
Oncotarget; 2015 Oct; 6(30):30035-56. PubMed ID: 26375443
[TBL] [Abstract][Full Text] [Related]
37. Imaging proteolysis by living human glioma cells.
Sameni M; Dosescu J; Sloane BF
Biol Chem; 2001 May; 382(5):785-8. PubMed ID: 11517931
[TBL] [Abstract][Full Text] [Related]
38. Modeling the cholesteatoma microenvironment: coculture of HaCaT keratinocytes with WS1 fibroblasts induces MMP-2 activation, invasive phenotype, and proteolysis of the extracellular matrix.
Laeeq S; Faust R
Laryngoscope; 2007 Feb; 117(2):313-8. PubMed ID: 17204986
[TBL] [Abstract][Full Text] [Related]
39. Functional screening with a live cell imaging-based random cell migration assay.
van Roosmalen W; Le Dévédec SE; Zovko S; de Bont H; van de Water B
Methods Mol Biol; 2011; 769():435-48. PubMed ID: 21748693
[TBL] [Abstract][Full Text] [Related]
40. In Vitro Engulfment Assay to Measure Phagocytic Activity of Astrocytes Using Synaptosomes.
Byun YG; Chung WS
Methods Mol Biol; 2019; 1938():155-168. PubMed ID: 30617979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
